Ignite Creation Date:
2024-05-06 @ 1:56 AM
Last Modification Date:
2024-10-26 @ 11:11 AM
Study NCT ID:
NCT01933347
Status:
COMPLETED
Last Update Posted:
2020-02-06
First Post:
2013-08-28
Brief Title:
Third-line Treatment of Gefitinib in NSCLC Patients
Sponsor:
Organization:
Guangdong Association of Clinical Trials